Maintaining Ongoing Readiness for Routine Inspections
Maintaining Ongoing Readiness for Routine Inspections How to Maintain Continuous Readiness for Routine Inspections Why Ongoing Inspection Readiness Matters Routine inspections by regulatory authorities like the FDA, EMA, MHRA, and others are standard practice in clinical research. These inspections aim to ensure Good Clinical Practice (GCP) compliance, data integrity, and participant safety across trials. Although…
Read More “Maintaining Ongoing Readiness for Routine Inspections” »